Reduction of | Intervention | Control | ||||||
---|---|---|---|---|---|---|---|---|
n1 | mean2 | 95% CI | p-value3 | n1 | mean | 95% CI | p-value3 | |
primary outcome measure | ||||||||
HbA1c (%) | 590 | 0.41 | [0.32; 0.50] | <0.0001 | 754 | 0.28 | [0.21; 0.35] | <0.0001 |
secondary outcome measures | ||||||||
Creatinine (μmol/l) | 586 | -0.88 | [-2.65; 0.88] | 0.165 | 739 | 0.88 | [-0.88; 2.65] | 0.504 |
Triglycerides (mmol/l) | 585 | 0.15 | [0.02; 0.27] | 0.021 | 736 | 0.09 | [0.00; 0.17] | 0.046 |
Cholesterol (mmol/l) | 585 | 0.06 | [-0.01; 0.14] | 0.112 | 736 | 0.01 | [-0.06; 0.07] | 0.797 |
HDL (mmol/l) | 585 | -0.02 | [-0.04; -0.01] | 0.011 | 736 | -0.01 | [-0.03; 0.01] | 0.209 |
LDL (mmol/l) | 585 | -0.01 | [-0.08; 0.07] | 0.864 | 736 | 0.04 | [-0.02; 0.10] | 0.161 |
RR systolic (mmHg) | 561 | 2.49 | [1.03; 3.94] | 0.001 | 691 | 0.68 | [-0.46; 1.83] | 0.241 |
RR diastolic (mmHg) | 561 | 1.16 | [0.35; 1.98] | 0.005 | 691 | 0.61 | [-0.08; 1.30] | 0.084 |
BMI | 568 | 0.31 | [0.17; 0.44] | <0.001 | 695 | 0.04 | [-0.09; 0.16] | 0.540 |